← Retour 🔗 Vue partagée — Acme Corporation · Lecture seule

Eureka Biotech call

Vinnova · SE
2.9
Score global

Résumé

Do you want to collaborate in biotechnology with Switzerland, Germany, France, Canada, South Korea and several other countries? Here is an opportunity for both large and small companies, universities and research institutes to create international R&D projects with funding from Sweden (Vinnova) and the other participating countries in the call through Eureka Network projects. The projects that are…

Analyse d'adéquation

This is a Eureka Biotech call focused on biotechnology innovation, which does not align with Acme Corporation's primary domains of semiconductors and AI. While the call does involve R&D and international collaboration (both within client's strategic interests), the sector mismatch is fundamental and disqualifying.

Point de vigilance

Verify whether biotechnology encompasses any semiconductor or AI-adjacent applications (e.g., biotech sensors, AI in drug discovery) that might justify a secondary relevance check.

Scores détaillés

Pertinence 3.0/10
Urgence 6.0/10
Adéquation stratégique 2.0/10

Brief exécutif

Low

Pas d'analyse approfondie — ce score ≤ 6,0 n'a pas déclenché l'analyse détaillée. Voir l'analyse d'adéquation ci-dessus.

Description

Do you want to collaborate in biotechnology with Switzerland, Germany, France, Canada, South Korea and several other countries? Here is an opportunity for both large and small companies, universities and research institutes to create international R&D projects with funding from Sweden (Vinnova) and the other participating countries in the call through Eureka Network projects. The projects that are funded must have the potential to develop a product, process or service that can be commercialized. You apply to Eureka between March 31, 2026 and September 25, 2026, and to Vinnova with your national application between March 31, 2026 and September 30, 2026 at 2:00 PM.

Source officielle
Voir l'appel ↗